Rising breast cancer diagnosis rates and more aggressive disease in younger women underscore importance of early detection and care with effective and tolerable treatments that help prevent cancer ...

A high omega-3, low omega-6 diet with fish oil reduced the Ki-67 index by 15% in prostate cancer patients on active surveillance. The control group showed a 24% increase in the Ki-67 index, ...

Twenty patients (10 pre- and nine postmenopausal women, and one male) were enrolled in the lasofoxifene arm of the study, during which early Ki67 suppression in premenopausal patients was seen in ...

Twenty patients (10 pre- and nine postmenopausal women, and one male) were enrolled in the lasofoxifene arm of the study, during which early Ki67 suppression in premenopausal patients was seen in the ...

Dr. Iser states, "Ki67 is therefore also very well suited as a predictive biomarker that can provide information on the suitability of a specific form of treatment, including thoracic surgery.

Patients who met the clinical eligibility criteria were registered, and Ki67 immunohistochemical analysis was performed centrally. Patients with a Ki67 index of 13.25% or less were enrolled and ...

The FDA has removed the Ki-67 score requirement for selecting patients with HR-positive, HER2-negative early breast cancer for Verzenio treatment after surgery, Lilly said Friday. Now, eligible ...

An FDA approval put Ki-67 scoring — which may predict tumor growth — in the spotlight, but what that means long term to patients depends on who you ask. The speed at which cancer cells grow can be an ...

1 The current approval is for those with hormone receptor–positive, HER2-negative, node-positive disease at high risk of recurrence and a Ki67 score ≥ 20% as measured by an FDA-approved test. Ki67 was ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- With guidance from Ki67 proliferation marker screening, older women with low-risk luminal A breast cancer ...